Literature DB >> 2687873

An efficient method for generating proteins with altered enzymatic properties: application to beta-lactamase.

A R Oliphant1, K Struhl.   

Abstract

Random-sequence or highly degenerate oligonucleotides have been useful for defining functionally important sequences both in proteins and in nucleic acids. In this approach, such oligonucleotides are used to replace a segment of DNA required for a desired function, and functional sequences are identified by an appropriate genetic or biochemical selection. Here, a collection of 500,000 [corrected] altered beta-lactamase proteins was generated by cloning a mixed-base oligonucleotide in place of the sequences coding for a 17-amino acid portion of the enzyme's active site. Approximately 2000 enzymes from this collection were able to confer ampicillin resistance on Escherichia coli. Fifty-eight of these were chosen for further study after characterization with various beta-lactam substrates. beta-Lactamases having altered specificity against different antibiotics, resistance to the suicide inhibitors clavulanic acid and sulbactam, and temperature-dependent activities were obtained. The amino acid residues responsible for these altered properties as well as for basic enzyme activity are defined. This approach should prove to be an effective and general tool for creating proteins with novel properties, especially in situations in which a high-resolution structure of the protein is not known.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2687873      PMCID: PMC298440          DOI: 10.1073/pnas.86.23.9094

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Bacterial resistance to beta-lactam antibiotics: crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.5 A resolution.

Authors:  O Herzberg; J Moult
Journal:  Science       Date:  1987-05-08       Impact factor: 47.728

2.  Defining the consensus sequences of E.coli promoter elements by random selection.

Authors:  A R Oliphant; K Struhl
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

3.  The use of random-sequence oligonucleotides for determining consensus sequences.

Authors:  A R Oliphant; K Struhl
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Cloning of random-sequence oligodeoxynucleotides.

Authors:  A R Oliphant; A L Nussbaum; K Struhl
Journal:  Gene       Date:  1986       Impact factor: 3.688

5.  Defining the sequence specificity of DNA-binding proteins by selecting binding sites from random-sequence oligonucleotides: analysis of yeast GCN4 protein.

Authors:  A R Oliphant; C J Brandl; K Struhl
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

6.  Selective chemical catalysis by an antibody.

Authors:  S J Pollack; J W Jacobs; P G Schultz
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

7.  A stereospecific cyclization catalyzed by an antibody.

Authors:  A D Napper; S J Benkovic; A Tramontano; R A Lerner
Journal:  Science       Date:  1987-08-28       Impact factor: 47.728

8.  Combinatorial cassette mutagenesis as a probe of the informational content of protein sequences.

Authors:  J F Reidhaar-Olson; R T Sauer
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

9.  A new class of yeast transcriptional activators.

Authors:  J Ma; M Ptashne
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

10.  Search for the optimal sequence of the ribosome binding site by random oligonucleotide-directed mutagenesis.

Authors:  K T Min; M H Kim; D S Lee
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

View more
  31 in total

1.  Novel human DNA alkyltransferases obtained by random substitution and genetic selection in bacteria.

Authors:  F C Christians; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Thirty-degree shift in optimum temperature of a thermophilic lipase by a single-point mutation: effect of serine to threonine mutation on structural flexibility.

Authors:  Monika Sharma; Rakesh Kumar; Ranvir Singh; Jagdeep Kaur
Journal:  Mol Cell Biochem       Date:  2017-02-11       Impact factor: 3.396

3.  Exploring the active site of chorismate mutase by combinatorial mutagenesis and selection: the importance of electrostatic catalysis.

Authors:  P Kast; M Asif-Ullah; N Jiang; D Hilvert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 4.  Catalytic properties of class A beta-lactamases: efficiency and diversity.

Authors:  A Matagne; J Lamotte-Brasseur; J M Frère
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

5.  Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamase.

Authors:  S Farzaneh; E B Chaibi; J Peduzzi; M Barthelemy; R Labia; J Blazquez; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 6.  In vivo versus in vitro screening or selection for catalytic activity in enzymes and abzymes.

Authors:  J Fastrez
Journal:  Mol Biotechnol       Date:  1997-02       Impact factor: 2.695

7.  Directed evolution studies with combinatorial libraries of T4 lysozyme mutants.

Authors:  P A Patten; T Sonoda; M M Davis
Journal:  Mol Divers       Date:  1996-02       Impact factor: 2.943

8.  Hamming chromatography.

Authors:  A Schwienhorst; A Schober; R Günther; P F Stadler
Journal:  Mol Divers       Date:  1996-05       Impact factor: 2.943

Review 9.  Viewing protein fitness landscapes through a next-gen lens.

Authors:  Jeffrey I Boucher; Pamela Cote; Julia Flynn; Li Jiang; Aneth Laban; Parul Mishra; Benjamin P Roscoe; Daniel N A Bolon
Journal:  Genetics       Date:  2014-10       Impact factor: 4.562

10.  Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases.

Authors:  J Blazquez; M I Morosini; M C Negri; M Gonzalez-Leiza; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.